September 25, 2020 12:30-13:30 CST

NextGen Omics Series UK: Virtual

November 4-6th, 2020, GMT

Join us for this year’s NextGen Omics Conference, now online

Share on facebook
Share on twitter
Share on linkedin

Join Pillar Biosciences and over 1000 other leaders in NGS at this year’s NextGen Omics UK Conference, now online. Visit our virtual booth, and tune in for our featured presentation on our Lung and Colon Cancer Assay, now approved for in vitro diagnostic use in Europe.

Featured Presentation

“Introduction to the IVD Pillar® ONCO/Reveal™ Dx Lung and Colon Cancer Assay”

Gang Song, Ph.D., Founder, President and CEO of Pillar Biosciences

Presentation Highlights

  • Pillar Biosciences’ history, mission, vision and clinical focus
  • Overview of the CE-IVD ONCO/Reveal Dx Lung and Colon Cancer Assay
  • Analytical and clinical validation and verification of the ONCO/Reveal Dx Lung and Colon Cancer Assay

View the presentation here following the virtual event

Speaker Bio

Dr. Gang Song is CEO, President and Founder of Pillar Biosciences. He is also a co-founder of AffyImmune Therapeutics, a cellular immunotherapy company, and a Venture Partner at ORI Capital. Dr. Song co-invented Pillar Biosciences’ SLIMamp® technology. Previously, Dr. Song was a Technical Lead at Integrated Genetics, LabCorp (previously Genzyme Genetics), and Project Lead at IQuum (later acquired by Roche Molecular Diagnostics). Dr. Song completed his postdoctoral training in Dr. Timothy Springer’s laboratory at Harvard Medical School and received his Ph.D. from Shanghai Medical College of Fudan University, China.

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

Scroll to Top